Morgan Stanley’s Opthea Limited American Depositary Shares OPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-765
Closed -$2.57K 8570
2025
Q3
$2.57K Hold
765
﹤0.01% 7258
2025
Q2
$2.57K Hold
765
﹤0.01% 7174
2025
Q1
$2.61K Sell
765
-2,600
-77% -$11.5K ﹤0.01% 7121
2024
Q4
$13.2K Buy
+3,365
New +$13.4K ﹤0.01% 6705
2024
Q2
Sell
-21
Closed -$86 8105
2024
Q1
$86 Sell
21
-979
-98% -$3.07K ﹤0.01% 7387
2023
Q4
$2.95K Hold
1,000
﹤0.01% 6964
2023
Q3
$1.74K Hold
1,000
﹤0.01% 7152
2023
Q2
$2.8K Hold
1,000
﹤0.01% 7121
2023
Q1
$3.95K Hold
1,000
﹤0.01% 7113
2022
Q4
$5.36K Hold
1,000
﹤0.01% 7131
2022
Q3
$6K Hold
1,000
﹤0.01% 7237
2022
Q2
$6K Hold
1,000
﹤0.01% 7387
2022
Q1
$6K Hold
1,000
﹤0.01% 7562
2021
Q4
$8K Buy
+1,000
New +$7.31K ﹤0.01% 7557
2021
Q3
Sell
-32
Closed 8300
2021
Q2
$0 Buy
+32
New +$285 ﹤0.01% 8030

Morgan Stanley's OPT Position: Q4 2025 in Review

Morgan Stanley sold out of Opthea Limited American Depositary Shares (OPT) in Q4 2025, closing a stake of 765 shares — an estimated $2.57K sold.

Morgan Stanley first reported a position in OPT in Q2 2021 and held it in 15 quarters. The position peaked at $13.2K in Q4 2024. 0 funds tracked by Wall St. Rank hold OPT as of Q4 2025.

  • Morgan Stanley reported no remaining Opthea Limited American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 765 Opthea Limited American Depositary Shares shares in Q4 2025, an estimated $2.57K.
  • Morgan Stanley first reported a position in Opthea Limited American Depositary Shares in Q2 2021 and held it in 15 quarters.
  • Morgan Stanley's Opthea Limited American Depositary Shares position peaked at $13.2K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Opthea Limited American Depositary Shares as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.